Track the Panacea Biotec Limited stock price and the full insider trade history of the company, a listed equity based in India. Shares trade on IN IN, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Panacea Biotec Limited has recorded 43 public disclosures. Market capitalisation: €25.3bn. The latest transaction was filed on 1 October 2025 (Purchase). Among the most active insiders: Sandeep Jain. The full history is accessible without an account.
43
Insider Decl.
0
Thresholds
€27,091
6 ops.
Buy Volume
€2m
37 ops.
Sell Volume
18Σ signal
Buys €27,091€2m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 18,276 of 25,564 companies
37.4
score / 100
Value
28
Quality
46
FCF yld-3.1%
Earn yld-0.3%
EV/EBITDA·
ROE·
Gross mgn52%
Net mgn-1.7%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.